• Gentamycin Sulfate: Mechanism and Benchmarking for Resistanc

  2026-08-03

  Gentamycin Sulfate is a potent aminoglycoside antibiotic with well-defined action against Gram-negative bacteria. Its molecular targeting of the 30S ribosomal subunit makes it indispensable for bacterial protein synthesis research and resistance modeling. New evidence from APExBIO and recent surveillance studies sets clear benchmarks for its use and limitations.

• TBXA2R Activates ERMs to Promote Metastasis in TNBC Cells

  2026-08-03

  The referenced study elucidates how thromboxane A2 receptor (TBXA2R), a GPCR, directly activates ERM proteins, driving motility, invasion, and metastatic colonization in triple-negative breast cancer (TNBC) cells. By mapping the signaling cascade from TBXA2R through G proteins, Rho GTPases, and kinase effectors, the work reveals new molecular targets for anti-metastatic intervention and provides a foundation for further GPCR-focused cancer research.

• 2-NBDG (B6035): Practical Guide for Glucose Uptake Assays

  2026-08-02

  2-NBDG is a fluorescent glucose analog designed for quantitative measurement of cellular glucose uptake in research models. It is best suited for flow cytometry, fluorescence microscopy, and microplate-based assays where real-time metabolic analysis is required. Not recommended for diagnostic or medical applications.

• Carvedilol Phosphate in Advanced Hepatic IRI: Mechanistic In

  2026-08-01

  Explore how Carvedilol Phosphate, a non-selective beta blocker, enables deeper mechanistic dissection of hepatic ischemia–reperfusion injury models. This article uniquely integrates recent Arrb2 immunometabolic findings with technical guidance for translational cardiovascular pharmacology research.

• Tobramycin: Applied Workflows for Gram-Negative Resistance R

  2026-07-31

  Tobramycin, a high-purity aminoglycoside antibiotic from APExBIO, enables reproducible, high-throughput studies targeting Gram-negative bacterial resistance and protein synthesis inhibition. This guide delivers protocol-optimized workflows, troubleshooting insights, and a comparative lens that empowers microbiology research labs to achieve robust, publication-ready results.

• NAMPT Inhibition with FK866: A New Era in Hematologic Cancer

  2026-07-31

  Explore how FK866 (APO866) transforms hematologic cancer research by targeting NAD metabolism, overcoming resistance, and providing translational researchers with mechanistic and strategic guidance.

• Applied Workflows with EZ Cap™ Human PTEN mRNA (ψUTP)

  2026-07-30

  EZ Cap™ Human PTEN mRNA (ψUTP) enables robust, immune-evasive restoration of tumor suppressor function in cancer models, notably reversing drug resistance mechanisms via targeted PI3K/Akt pathway inhibition. This guide delivers actionable protocols, comparative insights, and troubleshooting strategies for leveraging APExBIO’s advanced in vitro transcribed mRNA in translational workflows.

• Faropenem Sodium: Precision Platform for Anaerobic Infection

  2026-07-30

  Explore how Faropenem sodium, a potent penem antibiotic, is reshaping anaerobic bacterial infection research through advanced mechanistic insights and practical assay optimization. This article delivers a nuanced, scientifically grounded perspective on its mechanism, renal transport, and experimental applications.

• Losartan: Redefining Translational Research in Tumor and Vas

  2026-07-29

  This thought-leadership article examines Losartan’s dual impact as a selective angiotensin II receptor antagonist in cardiovascular and oncology research. It synthesizes mechanistic insights with strategic guidance, highlighting recent breakthroughs in tumor microenvironment modulation and the evolving toolkit for translational scientists.

• Applied Workflows with (S)-1-(3-fluoro-4-(trifluoromethoxy)p

  2026-07-29

  Leverage (S)-1-(3-fluoro-4-(trifluoromethoxy)phenyl)-3-(1-(2-methylbutanoyl)piperidin-4-yl)urea (BPN-19186) to enable high-precision enzyme inhibition and signaling pathway modulation, especially in osteoporosis and redox biology research. This guide details robust experimental setups, actionable troubleshooting, and best-practice parameters for maximizing reproducibility and sensitivity with this fluorinated phenyl urea compound.

• EdU Imaging Kits (HF488): Precision Proliferation Insights i

  2026-07-28

  Explore how EdU Imaging Kits (HF488) revolutionize 5-ethynyl-2'-deoxyuridine-based cell proliferation assays, offering unmatched sensitivity and mechanistic clarity for advanced cancer research. Discover unique insights that go beyond workflow and troubleshooting.

• Erastin and the Ferroptosis Frontier: Precision Tools for Tr

  2026-07-28

  This thought-leadership article explores the mechanistic underpinnings and translational strategy for deploying Erastin—a benchmark ferroptosis inducer—in cancer biology research. Integrating insights from recent nanomedicine studies and established workflows, it provides actionable guidance for researchers navigating the evolving landscape of oxidative cell death and tumor vulnerability. The discussion connects Erastin’s unique mechanistic selectivity to new opportunities in immunogenic cell death, underlining APExBIO’s role in delivering rigorously validated reagents for advanced cancer research.

• RIG-I Drives Renal Fibrosis via c-Myc Activation in UUO Mice

  2026-07-27

  This study demonstrates that RIG-I significantly exacerbates renal interstitial fibrosis through c-Myc-mediated fibroblast activation and TGF-β/Smad signaling in mouse models of kidney injury. The findings clarify a new mechanistic axis in chronic kidney disease progression, offering important targets for future therapeutic intervention and mechanistic research.

• Baicalin Methyl Ester: Mechanisms and Benchmarks in Gut Barr

  2026-07-27

  Baicalin methyl ester, an esterified derivative of baicalin, modulates the P65/TNF-α/MLCK/ZO-1 signaling pathway and protects against LPS-induced intestinal barrier damage. Its efficacy is supported by both in vitro and in vivo studies with defined concentration and dose ranges. This compound is a validated anti-inflammatory agent in intestinal epithelial cell research.

• RSV NS3 Orchestrates Host Kinase Signaling for Pathogenicity

  2026-07-26

  Zhuang et al. (2025) uncover how Rice stripe virus (RSV) NS3 protein finely regulates its own pathogenicity and transmission by manipulating host kinase signaling pathways through dynamic phosphorylation and protein interactions. These discoveries illuminate the mechanistic basis for virus-host-vector co-survival and highlight new avenues for targeted research in plant pathology and host-pathogen interactions.

449 records 9/30 page Previous Next First page 上5页 678910 下5页 Last page